Cargando…
Immunogenicity of MultiTEP platform technology-based Tau vaccine in non-human primates
Pathological forms of Tau protein are directly associated with neurodegeneration and correlate with Alzheimer’s Disease (AD) symptoms, progression, and severity. Previously, using various mouse models of Tauopathies and AD, we have demonstrated the immunogenicity and efficacy of the MultiTEP-based a...
Autores principales: | Hovakimyan, Armine, Zagorski, Karen, Chailyan, Gor, Antonyan, Tatevik, Melikyan, Levon, Petrushina, Irina, Batt, Dash G., King, Olga, Ghazaryan, Manush, Donthi, Aashrit, Foose, Caitlynn, Petrovsky, Nikolai, Cribbs, David H., Agadjanyan, Michael G., Ghochikyan, Anahit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556597/ https://www.ncbi.nlm.nih.gov/pubmed/36224191 http://dx.doi.org/10.1038/s41541-022-00544-3 |
Ejemplares similares
-
Immunogenicity of MultiTEP-Platform-Based Recombinant Protein Vaccine, PV-1950R, Targeting Three B-Cell Antigenic Determinants of Pathological α-Synuclein
por: Zagorski, Karen, et al.
Publicado: (2022) -
Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice
por: Davtyan, Hayk, et al.
Publicado: (2019) -
A MultiTEP platform-based epitope vaccine targeting the phosphatase activating domain (PAD) of tau: therapeutic efficacy in PS19 mice
por: Hovakimyan, Armine, et al.
Publicado: (2019) -
Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies
por: Kim, Changyoun, et al.
Publicado: (2022) -
Author Correction: Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies
por: Kim, Changyoun, et al.
Publicado: (2023)